top of page

Drug Shortage: 0.9% Sodium Chloride Injection Bags 1000ml - Extended until Feb 2026

Dear Healthcare Professional,

 

Shortage of BAXTER 0.9% SODIUM CHLORIDE 9g/L injection BP bag AHB1324 (ARTG: 48520) and alternative supply arrangement under section 19A of the Therapeutic Goods Act 1989 

 

The Australian registered medicine, BAXTER 0.9% SODIUM CHLORIDE 9g/L injection BP bag AHB1324 (ARTG: 48520), is currently in shortage due to manufacturing issues.

 

Pro Pharmaceuticals Group has arranged for the supply of an alternative product, Sodium chloride 0.9% solution for infusion in FREEFLEX bag 1000mL (Fresenius Kabi, Netherlands). This product is NOT registered in Australia and supply is authorised under an approval granted by the Therapeutic Goods Administration (TGA) under section 19A of the Therapeutic Goods Act 1989 until 28th Feb 2026.


Please pass this onto your members.


For any orders please email to orders@propg.com.au or visit our website www.propg.com.au


ree

 
 
Recent Posts
Archive
Search By Tags
Follow Us
  • Twitter Social Icon
  • Google+ Basic Square

TEL:

1300 077 674 (1300 0 PRO PG)

FAX:

(03) 86790397

AUSTRALIA​      |  GERMANY  |      POLAND

Legal & Trademark Notice
© 2025 Pro Pharmaceuticals Group Pty Ltd. All rights reserved.
Pro PG, CheckMed, and their respective logos are registered trademarks owned worldwide by Pro Pharmaceuticals Group Pty Ltd.
Pro Pharmaceuticals Group operates globally through associated entities, including CTS Pharmaceuticals Pty Ltd (Australia), Jemstar Sp. z o.o. (Poland), and Pro Pharmaceuticals Group NZ Ltd (New Zealand).

International Tax Registrations:
ABN 20 605 457 430 (Australia) | VAT DE401757398 (EU VAT ID) | Steuernummer 15/460/00493 (Germany) | VAT PL5263362401 (Poland) | VAT NL825524295B01 (Netherlands).

bottom of page